causal
Analysis v1
Strong Support
Tesamorelin improves the ratio of bad cholesterol to good cholesterol by about 7% in HIV patients on medication, which is better for heart health. This finding is from the abstract summary - full study details were not available
62
0
Evidence from Studies
Supporting (1)
62
Community contributions welcome
62
Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data.
Randomized Controlled Trial
Human
2010 SepContradicting (0)
0
Community contributions welcome
No contradicting evidence found